June 19, 2017
Mindstrong Health, the mental health startup that former NIMH director Dr. Thomas Insel left Verily for last month, has raised $14 million. Foresite Capital and ARCH Venture Partners led the round, with additional participation from Optum Ventures, Berggruen Holdings, and the One Mind Brain Health Impact Fund.
Although it has been reported that Insel left Verily to start Mindstrong, the startup...
May 19, 2017
The days of claiming artificial intelligence as a feature that set one startup or company apart from the others are over. These days, one would be hard-pressed to find any technology company attracting venture funding or partnerships that doesn’t posit to use some form of machine learning. But for companies trying to innovate in healthcare using artificial intelligence, the stakes are...
May 18, 2017
As Scott Gottlieb kicks off his tenure as FDA commissioner, former commissioner Robert Califf has a new gig as well. Califf revealed in a blog post that he has taken a job at Verily, the life sciences arm of Alphabet, as well as returning to professorial positions at Duke and Stanford. Although the details of his role are still unclear, Califf will work on Verily’s Baseline study, an effort to...
May 11, 2017
Roy J.E.M. Raymann, who, as we reported yesterday, left Apple's sleep team a month ago, has moved to SleepScore Labs, a joint venture between ResMed, Dr. Oz Media, and Pegasus Capital Advisors. He will serve as Vice President of Sleep Science and Scientific Affairs.
First announced this year at CES, SleepScore Labs is "currently in the process of examining how people sleep by compiling and...
May 10, 2017
Dr. Thomas Insel, former director of the National Institute of Mental Health, has left Verily after a little under two years. According to a report in Nature, Insel will be starting a new startup called Mindstrong that will be focused on using smartphones to detect mental health conditions.
Insel joined Verily, a subsidiary of Alphabet that at the time was called Google Life Sciences, in...
April 20, 2017
Alphabet-owned Verily has launched the Project Baseline Study, a collaborative effort with Stanford Medicine and Duke University School of Medicine to amass a large collection of broad phenotypic health data in hopes of developing a well-defined reference of human health.
Project Baseline aims to gather data from around 10,000 participants, each of whom will be followed for four years, and will...
April 17, 2017
Verily has debuted a new health-tracking wearable designed for use in a series of observational and longitudinal studies. With the aptly dubbed Study Watch – which is not available for consumer purchase – the Alphabet subsidiary formerly known as Google Life Sciences aims to push new boundaries in the size, scope and sophistication of wearable data-gathering.
Featuring numerous physiological and...
March 28, 2017
Consistency and dedication may the hallmarks of success for fitness, but that doesn’t mean the apps to support exercise or diet need to be narrow in their focus. Operating on the idea that consumers want flexibility in how they pursue their health goals, Adidas has released a new app that offers a wide variety of content and tracking for multiple aspects of health.
All Day, which is now...
March 1, 2017
After the latest in a series of successful quarters (with $171.2 million in revenue, up 31 percent year over year), DexCom is queuing up some big product launches. On yesterday’s Q4 earnings call, CEO Kevin Sayer provided more detail about the forthcoming G6 continuous glucose monitor as well as the first products to come out of DexCom’s partnership with Verily.
“In a year of much confusion and...
January 26, 2017
Verily, the Alphabet subsidiary formerly known as Google Life Sciences, raised $800 million in funding today from Temasek, a Singapore-based investment company. Temasek will take a minority stake in the company and nominate a member to the company's board.
“Temasek has a history of thoughtful and enduring capital investments, including in life sciences and healthcare, and this commitment to a...